Suppr超能文献

“所有疾病都因人而异”:一项关于支气管扩张症患者治疗依从性观点的定性研究

'All illness is personal to that individual': a qualitative study of patients' perspectives on treatment adherence in bronchiectasis.

作者信息

McCullough Amanda R, Tunney Michael M, Elborn J Stuart, Bradley Judy M, Hughes Carmel M

机构信息

Clinical & Practice Research Group, School of Pharmacy, Queen's University Belfast, Belfast, UK.

Centre for Infection and Immunity, School of Medicine, Dentistry and Biomedical Sciences, Queen's University Belfast, Belfast, UK.

出版信息

Health Expect. 2015 Dec;18(6):2477-88. doi: 10.1111/hex.12217. Epub 2014 Jun 20.

Abstract

BACKGROUND

Adherence to treatment is low in bronchiectasis and is associated with poorer health outcomes. Factors affecting adherence decisions have not been explored in patients with bronchiectasis.

OBJECTIVE

We aimed to explore patients' perspectives on adherence, factors affecting adherence decision making and to develop a conceptual model explaining this decision-making process in adults with bronchiectasis.

METHODS

Adults with bronchiectasis participated in one-to-one semi-structured interviews. Interviews were audio-recorded, transcribed verbatim and analysed independently by two researchers using thematic analysis. Data from core themes were extracted, categorized into factors affecting adherence decision making and used to develop the conceptual model.

RESULTS

Participants' beliefs about treatment, the practical aspects of managing treatment, their trust in health-care professionals and acceptance of disease and treatment were important aspects of treatment adherence. The conceptual model demonstrated that adherence decisions were influenced by participants' individual balance of barriers and motivating factors (treatment-related, disease-related, health-care-related, personal and social factors).

CONCLUSION

Adherence decision-making in bronchiectasis is complex, but there is the potential to enhance adherence by understanding patients' specific barriers and motivators to adherence and using this to tailor adherence strategies to individual patients and treatments.

摘要

背景

支气管扩张症患者的治疗依从性较低,且与较差的健康结局相关。支气管扩张症患者中影响依从性决策的因素尚未得到探讨。

目的

我们旨在探究患者对依从性的看法、影响依从性决策的因素,并建立一个概念模型来解释成年支气管扩张症患者的这一决策过程。

方法

成年支气管扩张症患者参与一对一的半结构化访谈。访谈进行录音,逐字转录,并由两名研究人员使用主题分析法独立分析。从核心主题中提取数据,归类为影响依从性决策的因素,并用于建立概念模型。

结果

患者对治疗的信念、治疗管理的实际方面、对医护人员的信任以及对疾病和治疗的接受程度是治疗依从性的重要方面。概念模型表明,依从性决策受患者个体障碍与激励因素(治疗相关、疾病相关、医护相关、个人和社会因素)平衡的影响。

结论

支气管扩张症的依从性决策很复杂,但通过了解患者依从性的具体障碍和激励因素,并据此为个体患者和治疗制定依从性策略,有可能提高依从性。

相似文献

3
Patient Perceived Barriers and Enablers to Medication Adherence in the Treatment of Depression: A Qualitative Study.
J Prim Care Community Health. 2024 Jan-Dec;15:21501319241286313. doi: 10.1177/21501319241286313.
5
Patients' Perspective of Medication Adherence in Chronic Conditions: A Qualitative Study.
Adv Ther. 2016 Oct;33(10):1740-1754. doi: 10.1007/s12325-016-0394-6. Epub 2016 Aug 9.
6
Patient perspectives of airway clearance techniques in bronchiectasis.
Physiother Theory Pract. 2024 Mar 3;40(3):505-515. doi: 10.1080/09593985.2022.2126741. Epub 2022 Sep 20.
7
Understanding Medication Nonadherence in Crohn's Disease Patients: A Qualitative Evaluation.
Inflamm Bowel Dis. 2024 Nov 4;30(11):2046-2056. doi: 10.1093/ibd/izad296.
8
Physiotherapist perspectives of airway clearance techniques in bronchiectasis.
Physiother Theory Pract. 2023 Apr;39(4):785-793. doi: 10.1080/09593985.2022.2028326. Epub 2022 Jan 27.
10
Factors affecting nebulised medicine adherence in adult patients with cystic fibrosis: a qualitative study.
Int J Clin Pharm. 2015 Feb;37(1):86-93. doi: 10.1007/s11096-014-0043-6. Epub 2014 Nov 29.

引用本文的文献

1
Integrating humanities curricula in medical education: a literature review.
MedEdPublish (2016). 2018 Aug 10;6:90. doi: 10.15694/mep.2017.000090.2. eCollection 2017.
2
Patient attitudes to nebulised antibiotics in the treatment of bronchiectasis: a mixed-methods study.
ERJ Open Res. 2023 May 30;9(3). doi: 10.1183/23120541.00735-2022. eCollection 2023 May.
3
Pilot Evaluation of a Management Toolkit for Airway Clearance Therapy in Bronchiectasis (IMPACT BE).
ATS Sch. 2023 Jan 30;4(1):76-86. doi: 10.34197/ats-scholar.2022-0061IN. eCollection 2023 Mar.
4
Assessment of factors and interventions towards therapeutic adherence among persons with non-cystic fibrosis bronchiectasis.
ERJ Open Res. 2022 Nov 7;8(4). doi: 10.1183/23120541.00340-2022. eCollection 2022 Oct.
5
7
Measuring airway clearance outcomes in bronchiectasis: a review.
Eur Respir Rev. 2020 Apr 29;29(156). doi: 10.1183/16000617.0161-2019. Print 2020 Jun 30.
8
Positive expiratory pressure therapy versus other airway clearance techniques for bronchiectasis.
Cochrane Database Syst Rev. 2017 Sep 27;9(9):CD011699. doi: 10.1002/14651858.CD011699.pub2.

本文引用的文献

1
Respiratory health and disease in Europe: the new European Lung White Book.
Eur Respir J. 2013 Sep;42(3):559-63. doi: 10.1183/09031936.00105513.
5
Ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis: a phase II randomised study.
Eur Respir J. 2013 May;41(5):1107-15. doi: 10.1183/09031936.00071312. Epub 2012 Sep 27.
6
British Thoracic Society national bronchiectasis audit 2010 and 2011.
Thorax. 2012 Oct;67(10):928-30. doi: 10.1136/thoraxjnl-2012-201983. Epub 2012 Jul 17.
8
Expert patient self-management program versus usual care in bronchiectasis: a randomized controlled trial.
Arch Phys Med Rehabil. 2011 Aug;92(8):1194-201. doi: 10.1016/j.apmr.2011.03.012.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验